Results 271 to 280 of about 128,630 (294)

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

New England Journal of Medicine, 1992
Jens J Holst Dmsci, Bo Ahrén
exaly  

Glucagon-like peptide-1

Trends in Endocrinology & Metabolism
openaire   +2 more sources

Glucagon-Like Peptide-1

2010
openaire   +1 more source

Glucagon-like-peptide-1

Reactions Weekly, 2014
openaire   +1 more source

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Cell Metabolism, 2018
Daniel J Drucker
exaly  

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Circulation, 2019
Stephen Wiviott, Itamar Raz, Marc P Bonaca   +2 more
exaly  

A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

Circulation, 2013
Ilya M Mukovozov, Ren-Ke Li, Filio Billia   +2 more
exaly  

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake

Nature Medicine, 2000
Jesper Thulesen, Niels Vrang
exaly  

Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2

Annual Review of Physiology, 2014
Daniel J Drucker
exaly  

Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?

Lancet, The, 2019
Jens J Holst Dmsci
exaly